The European Medicine Agency has announced a review of ibuprofen medicines taken at high doses because of the risk of cardiovascular disease. The review covers medicines taken orally, but not topical treatments such as creams and gels. ---Subscribe to MedNous to access this article--- Regulation & Policy
